UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 121

Sortiert nach

Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma

Cancer research (Chicago, Ill.), 2018-06, Vol.78 (11), p.3002-3013

2018

Volltextzugriff (PDF)

PRC2 Heterogeneity Drives Tumor Growth in Medulloblastoma

Cancer research (Chicago, Ill.), 2022-08, Vol.82 (16), p.2874-2886

2022

Volltextzugriff (PDF)

Identification of Novel Susceptibility Loci and Genes for Prostate Cancer Risk: A Transcriptome-Wide Association Study in Over 140,000 European Descendants

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13), p.3192-3204

2019

Volltextzugriff (PDF)

Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13), p.3502-3512

2017

Volltextzugriff (PDF)

Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation : Identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer

Cancer research (Chicago, Ill.), 2006, Vol.66 (1), p.453-463

2006

Volltextzugriff (PDF)

Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells

Cancer research (Chicago, Ill.), 2006-10, Vol.66 (20), p.10040-10047

2006

Volltextzugriff (PDF)

Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer

Cancer research (Chicago, Ill.), 2003-11, Vol.63 (21), p.7497-7506

2003

Volltextzugriff (PDF)

Beyond Rapalog Therapy: Preclinical Pharmacology and Antitumor Activity of WYE-125132, an ATP-Competitive and Specific Inhibitor of mTORC1 and mTORC2

Cancer research (Chicago, Ill.), 2010-01, Vol.70 (2), p.621-631

2010

Volltextzugriff (PDF)

Therapeutic Efficacy of a Novel Focal Adhesion Kinase Inhibitor TAE226 in Ovarian Carcinoma

Cancer research (Chicago, Ill.), 2007-11, Vol.67 (22), p.10976-10983

2007

Volltextzugriff (PDF)

Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer

Cancer research (Chicago, Ill.), 2002-09, Vol.62 (17), p.4968-4976

2002

Volltextzugriff (PDF)

The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer

Cancer research (Chicago, Ill.), 2016-04, Vol.76 (7), p.1825-1836

2016

Volltextzugriff (PDF)

Abstract 2666: HMGA1: An epigenetic switch required for MPN progression by inducing GATA-2 and cell cycle progression through enhancer rewiring

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2666-2666

2021

Volltextzugriff (PDF)

ATG5-Dependent Autophagy Uncouples T-cell Proliferative and Effector Functions and Separates Graft-versus-Host Disease from Graft-versus-Leukemia

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4), p.1063-1075

2021

Volltextzugriff (PDF)

Abstract 5080: Decursinol intercepts LNCaP human prostate cancer xenograft growth bypassing androgen receptor-prostate specific antigen axis

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.5080-5080

2019

Volltextzugriff (PDF)

Abstract 4521: Mutant Kras expression triggers clonal acinar cell expansion as an early step in pancreas cancer

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.4521-4521

2019

Volltextzugriff (PDF)

Abstract 2663: Identification of differential immune landscapes in high-grade serous ovarian tumors of high-risk patients by imaging mass cytometry

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.2663-2663

2020

Volltextzugriff (PDF)

Abstract 2744: The immune landscape of recurrent ovarian carcinoma

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2744-2744

2021

Volltextzugriff (PDF)

Abstract 1155: Subcutaneous intratumoral administration of a novel oncolytic virus leads to eradication of peritoneal disseminated pancreatic cancer in nude mice

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1155-1155

2021

Volltextzugriff (PDF)

Abstract 1612: Tumor intrinsic changes determine immune-checkpoint response in Richter's transformation

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1612-1612

2021

Volltextzugriff (PDF)

Abstract 2749: The unique tumor immune microenvironment of clear cell ovarian carcinoma

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2749-2749

2021

Volltextzugriff (PDF)

Abstract 780: Racial disparities in death from cardiovascular disease for patients with prostate cancer: A population-based study

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.780-780

2021

Volltextzugriff (PDF)

Abstract 839: Association of bowel movement frequency and laxative use with risk of hepatocellular carcinoma in US women and men

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.839-839

2021

Volltextzugriff (PDF)

Abstract C22: Loss of KDM6A promotes pancreatic cancer progression by upregulating epithelial-mesenchymal transition pathway

Cancer research (Chicago, Ill.), 2019-12, Vol.79 (24_Supplement), p.C22-C22

2019

Volltextzugriff (PDF)

Abstract PS10-14: Efficacy and safety of palbociclib (PAL) in patients (pts) with estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) with preexisting conditions: A post hoc analysis of PALOMA-2

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS10-14-PS10-14

2021

Volltextzugriff (PDF)

Abstract LB-266: Identification of novel checkpoint kinase inhibitor ASR352 with selective activity against 5-FU resistant colorectal cancer cells

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.LB-266-LB-266

2018

Volltextzugriff (PDF)

1 – 25 von 121

Suche als RSS-Feed

Aktive Filter

ThemaMultidisciplinary Sciences

KollektionSingle Journals

Zeitschrift / SerieCancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(121)

Publikationsform

Artikel
(121)

Sprache

Englisch
(121)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Oncology
(18)
Science & Technology
(18)
Humans
(17)
Animals
(13)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Mice
(13)
Tumors
(11)
Female
(10)
Antineoplastic Agents
(9)
Pharmacology. Drug Treatments
(9)
Gynecology. Andrology. Obstetrics
(7)
Male
(7)
Cell Line, Tumor
(6)
Apoptosis - Drug Effects
(4)
Cell Growth Processes - Drug Effects
(4)
Female Genital Diseases
(4)
Mice, Nude
(4)
Middle Aged
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Menü

Weitere Dienste

Einstellungen

Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma

PRC2 Heterogeneity Drives Tumor Growth in Medulloblastoma

Identification of Novel Susceptibility Loci and Genes for Prostate Cancer Risk: A Transcriptome-Wide Association Study in Over 140,000 European Descendants

Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer

Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation : Identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer

Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells

Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer

Beyond Rapalog Therapy: Preclinical Pharmacology and Antitumor Activity of WYE-125132, an ATP-Competitive and Specific Inhibitor of mTORC1 and mTORC2

Therapeutic Efficacy of a Novel Focal Adhesion Kinase Inhibitor TAE226 in Ovarian Carcinoma

Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer

The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer

Abstract 2666: HMGA1: An epigenetic switch required for MPN progression by inducing GATA-2 and cell cycle progression through enhancer rewiring

ATG5-Dependent Autophagy Uncouples T-cell Proliferative and Effector Functions and Separates Graft-versus-Host Disease from Graft-versus-Leukemia

Abstract 5080: Decursinol intercepts LNCaP human prostate cancer xenograft growth bypassing androgen receptor-prostate specific antigen axis

Abstract 4521: Mutant Kras expression triggers clonal acinar cell expansion as an early step in pancreas cancer

Abstract 2663: Identification of differential immune landscapes in high-grade serous ovarian tumors of high-risk patients by imaging mass cytometry

Abstract 2744: The immune landscape of recurrent ovarian carcinoma

Abstract 1155: Subcutaneous intratumoral administration of a novel oncolytic virus leads to eradication of peritoneal disseminated pancreatic cancer in nude mice

Abstract 1612: Tumor intrinsic changes determine immune-checkpoint response in Richter's transformation

Abstract 2749: The unique tumor immune microenvironment of clear cell ovarian carcinoma

Abstract 780: Racial disparities in death from cardiovascular disease for patients with prostate cancer: A population-based study

Abstract 839: Association of bowel movement frequency and laxative use with risk of hepatocellular carcinoma in US women and men

Abstract C22: Loss of KDM6A promotes pancreatic cancer progression by upregulating epithelial-mesenchymal transition pathway

Abstract PS10-14: Efficacy and safety of palbociclib (PAL) in patients (pts) with estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) with preexisting conditions: A post hoc analysis of PALOMA-2

Abstract LB-266: Identification of novel checkpoint kinase inhibitor ASR352 with selective activity against 5-FU resistant colorectal cancer cells

Aktive Filter

Suchergebnisse filtern